Kewaunee Scientific Co. (NASDAQ:KEQU) Director Donald F. Shaw purchased 888 shares of the firm’s stock in a transaction that occurred on Wednesday, December 26th. The shares were acquired at an average cost of $28.78 per share, with a total value of $25,556.64. Following the completion of the transaction, the director now owns 21,250 shares in the company, valued at approximately $611,575. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.
Shares of Kewaunee Scientific Co. (NASDAQ KEQU) traded up $0.40 during trading on Friday, reaching $28.50. 1,800 shares of the company were exchanged, compared to its average volume of 2,900. The company has a current ratio of 2.12, a quick ratio of 1.58 and a debt-to-equity ratio of 0.04. Kewaunee Scientific Co. has a 12-month low of $20.95 and a 12-month high of $31.20. The stock has a market cap of $76.45, a PE ratio of 17.07 and a beta of 0.07.
Kewaunee Scientific (NASDAQ:KEQU) last announced its quarterly earnings results on Tuesday, December 5th. The technology company reported $0.62 earnings per share for the quarter. Kewaunee Scientific had a net margin of 3.28% and a return on equity of 10.61%. The firm had revenue of $41.47 million during the quarter.
Hedge funds have recently modified their holdings of the business. California Public Employees Retirement System acquired a new position in Kewaunee Scientific in the 2nd quarter worth $202,000. Northern Trust Corp lifted its holdings in Kewaunee Scientific by 2.3% in the 2nd quarter. Northern Trust Corp now owns 56,131 shares of the technology company’s stock worth $1,397,000 after buying an additional 1,284 shares in the last quarter. Hancock Holding Co. acquired a new position in Kewaunee Scientific in the 2nd quarter worth $203,000. Finally, Vanguard Group Inc. lifted its holdings in Kewaunee Scientific by 38.0% in the 2nd quarter. Vanguard Group Inc. now owns 59,560 shares of the technology company’s stock worth $1,486,000 after buying an additional 16,400 shares in the last quarter. Hedge funds and other institutional investors own 36.54% of the company’s stock.
WARNING: This piece was posted by American Banking News and is the property of of American Banking News. If you are accessing this piece on another website, it was illegally stolen and reposted in violation of United States & international trademark & copyright law. The legal version of this piece can be accessed at https://www.americanbankingnews.com/2018/01/05/kewaunee-scientific-co-kequ-director-purchases-25556-64-in-stock.html.
Kewaunee Scientific Company Profile
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.